Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
leukemia/phosphatase
Ссылка сохраняется в буфер обмена
13 полученные результаты
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
RELATED APPLICATIONS
This application claims the benefit of, and priority to, PCT serial number PCT/US06/034050, filed Aug. 31, 2006, presently pending, the disclosure of which is incorporated herein, in its entirety, by reference.
FIELD OF THE INVENTION
The invention relates generally to antibodies
Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
This invention is directed to the use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation, particularly proliferation of B lymphocytes.
Tyrosine phosphorylation is known to play an essential role in the control of lymphocyte function. This
Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
This invention is directed to the use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation, particularly proliferation of B lymphocytes.
Tyrosine phosphorylation is known to play an essential role in the control of lymphocyte function. This
18232, a novel dual specificity phosphatase and uses therefor
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
The intracellular phosphorylation of proteins is critical for a plethora of regulatory and signalling mechanisms in eukaryotic cells. Phosphorylation events can govern a wide range of cellular processes, including cell proliferation, differentiation, transcription, and
Phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
This invention is directed to the use of phosphotyrosine phosphatase inhibitors and tyrosine kinase activators for controlling cellular proliferation, particularly proliferation of lymphocytes.
Tyrosine phosphorylation is known to play an essential role in the control of
Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
This invention is directed to the use of phosphotyrosine phosphatase inhibitors and phosphotyrosine kinase activators for controlling cellular proliferation, particularly proliferation of lymphocytes.
Tyrosine phosphorylation is known to play an essential role in the
Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TABLE OF CONTENTS
1. Introduction
2. Background
2.1. Protein Phosphorylation and Signal Transduction
2.2. Protein Tyrosine Kinases
2.3. G-Proteins and Signal Transduction
2.4. BCR-ABL in the Development of Leukemias
3. Summary of the Invention
3.1. Abbreviations
4. Description of the Figures
5.
Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Intercellular protein tyrosine phosphorylation is regulated by extracellular stimuli, such as cytokines, to control cell growth, differentiation and functional activities. This signaling mechanism depends on the interplay of protein tyrosine kinases, which initiate
Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Intercellular protein tyrosine phosphorylation is regulated by extracellular stimuli, such as cytokines, to control cell growth, differentiation and functional activities. This signaling mechanism depends on the interplay of protein tyrosine kinases, which initiate
Method of diagnosing cancer and reagents therefor
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The present invention relates to the epigenetic state of a region of chromatin within the region of Chromosome 2 from about map position 2q14.1 to about 2q14.3 and its use to diagnose and/or monitor and/or prognose cancer
BACKGROUND OF THE INVENTION
1. General
This
Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
This invention is directed to the use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation, particularly proliferation of B lymphocytes.
Tyrosine phosphorylation is known to play an essential role in the control of lymphocyte function. This
Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention relates to the use of carprofen in mammals as a means of treating and preventing cartilage and subchondral bone injury and loss in the inflamed joints of such mammals. Such damage to the cartilage and subchondral bone is a natural sequelae of the process of osteoarthritis and
Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the field of treatment of neoplastic diseases and uncontrolled cell growth. More specifically, it relates to compositions and methods for treating tumors or cancers with combinations of a substance that activates
Самая полная база данных о лекарственных травах, подтвержденная наукой
- Работает на 55 языках
- Травяные лекарства, подтвержденные наукой
- Распознавание трав по изображению
- Интерактивная карта GPS - отметьте травы на месте (скоро)
- Прочтите научные публикации, связанные с вашим поиском
- Ищите лекарственные травы по их действию
- Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов
Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.
